Thursday, 29 September 2016

Dibelet




Dibelet may be available in the countries listed below.


Ingredient matches for Dibelet



Glibenclamide

Glibenclamide is reported as an ingredient of Dibelet in the following countries:


  • Singapore

International Drug Name Search

Magnesium Pidolate




Scheme

Prop.INN

ATC (Anatomical Therapeutic Chemical Classification)

A12CC08

CAS registry number (Chemical Abstracts Service)

0062003-27-4

Chemical Formula

C10-H12-Mg-N2-O6

Molecular Weight

280

Therapeutic Category

Mineral supplement

Chemical Name

Magnesium, bis(5-oxo-L-prolinato-N1,O2)-, (T-4)-

Foreign Names

  • Magnesii pidolas (Latin)
  • Pidolsäure, Magnesiumsalz (German)

Generic Names

  • Magnesium Pidolate (OS: BANM)
  • Magnesium 5-oxopyrrolidine-2-carboxylate (IS)
  • Magnesium pyroglutamate (IS)
  • Magnesii pidolas (PH: Ph. Eur. 6)
  • Magnesium Pidolate (PH: BP 2010, Ph. Eur. 6)

Brand Names

  • Actimag
    Iquinosa, Spain


  • Biomag
    Baliarda, Argentina


  • Mag 2
    Cooper, Burkina Faso; Cooper, Benin; Cooper, Central African Republic; Cooper, Congo; Cooper, Cote D'ivoire; Cooper, Cameroon; Cooper, France; Cooper, Gabon; Cooper, Guinea; Cooper, Luxembourg; Cooper, Madagascar; Cooper, Mali; Cooper, Mauritania; Cooper, Mauritius; Cooper, Niger; Cooper, Senegal; Cooper, Chad; Cooper, Togo; Cooper, Zaire; Cooperation Pharmaceutique Française, Tunisia; Galenica, Greece; Sanofi-Aventis, Switzerland; Sanofi-Aventis, Italy


  • Magnolve
    Vitoria, Portugal


  • Mg 2 Plus
    Opalia, Tunisia


  • Solumag
    Boehringer Ingelheim International, Luxembourg; Geymonat, Italy; Uni-Pharma, Greece


  • Top Mag
    Medipha, Tunisia


  • Top-Mag
    Aérocid, France

International Drug Name Search

Glossary

BANMBritish Approved Name (Modified)
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
Prop.INNProposed International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Comenter




Comenter may be available in the countries listed below.


Ingredient matches for Comenter



Mirtazapine

Mirtazapine is reported as an ingredient of Comenter in the following countries:


  • Argentina

  • Mexico

  • Venezuela

Selegiline

Selegiline hydrochloride (a derivative of Selegiline) is reported as an ingredient of Comenter in the following countries:


  • Ecuador

International Drug Name Search

Wednesday, 28 September 2016

Amitraz




In some countries, this medicine may only be approved for veterinary use.

Scheme

Prop.INN

CAS registry number (Chemical Abstracts Service)

0033089-61-1

Chemical Formula

C19-H23-N3

Molecular Weight

293

Therapeutic Category

Insecticide

Chemical Names

N-Methyl-N'-2,4-xylyl-N-(N-2,4-xylylformimidoyl)formamidine (WHO)

N²-(2,4-Dimethylphenyl)-N¹-[(2,4-dimethylphenylimino)methyl]-N¹-methylformimidamid (IUPAC)

Foreign Names

  • Amitrazum (Latin)
  • Amitraz (German)
  • Amitraz (French)
  • Amitraz (Spanish)

Generic Names

  • Amitraz (OS: BAN, USAN)
  • BTS 27419 (IS)
  • U 36059 (IS: Upjohn)
  • Amitraz (PH: BP vet. 2007, USP 32)

Brand Names

  • Aludex (veterinary use)
    Intervet, United Kingdom; Intervet, Ireland


  • Amidip (veterinary use)
    Virbac, South Africa


  • Amigard (veterinary use)
    Pfizer Animal Health, South Africa


  • Amipor (Amitraz and Cypermethrin, + Piperonyl Butoxide (veterinary use))
    Virbac, South Africa


  • Amitik (veterinary use)
    Coopers Animal Health, Australia


  • Amitix (veterinary use)
    Schering-Plough Animal Health, South Africa


  • Amitraz (veterinary use)
    Bayer Australia Ltd Animal Health, Australia; Virbac, Germany


  • Apitraz (veterinary use)
    Biowet Pulawy, Poland


  • Apivar (veterinary use)
    Veto-Pharma, France


  • Apiwarol (veterinary use)
    Biowet Pulawy, Poland


  • Biocani Tique (veterinary use)
    Véto-Centre, France


  • Biowar (veterinary use)
    Biowet Pulawy, Poland


  • Ceva Amitraz (veterinary use)
    Ceva Animal Health, South Africa


  • Crede Ecto Imatraz (veterinary use)
    Experto Vet, South Africa


  • Crede Ecto Tracypor (Amitraz and Cypermethrin (veterinary use))
    Experto Vet, South Africa


  • Delete (Amitraz and Deltamethrin, + Piperonyl Butoxide (veterinary use))
    Intervet, South Africa


  • Deltaderm Demadex (veterinary use)
    Delvet, Australia


  • Demotick (veterinary use)
    Intervet, Italy


  • Ectodex (veterinary use)
    Alfamed, Portugal; Intervet, Germany; Intervet, France; Intervet, Netherlands; Intervet, South Africa


  • MDB Cypertraz (Amitraz and Cypermethrin (veterinary use))
    Ceva Animal Health, South Africa


  • Milbitraz (veterinary use)
    Bayer Animal Health, South Africa


  • Mitaban (veterinary use)
    Pharmacia & Upjohn vet, United States


  • Pertanol (veterinary use)
    Sociedade Permutadora, S.A., Portugal


  • Preventic (veterinary use)
    Virbac, Australia; Virbac, Switzerland; Virbac, Italy; Virbac, Luxembourg; Virbac, South Africa; Virbac de Portugal, Portugal


  • Préventic (veterinary use)
    Virbac, France


  • Promeris Duo (Amitraz and Metaflumizone (veterinary use))
    CEVA Vetpharma, Sweden; Fort Dodge Animal Health, South Africa; Fort Dodge Santé Animale, France; Scanvet, Finland


  • Supatraz (veterinary use)
    Cipla Agrimed, South Africa


  • Sytraz (veterinary use)
    Iapsa Portuguesa Pecuária, Lda, Portugal


  • Taktic (veterinary use)
    Intervet, Austria; Intervet, Belgium; Intervet, France; Intervet, United Kingdom; Intervet, Ireland; Intervet, Italy; Intervet, Netherlands; Intervet, South Africa; Intervet / Schering-Plough Animal Health, New Zealand; Intervet Schering-Plough Animal Health, Portugal; Intervet/Schering-Plough Animal Health, Australia; Veterinaria, Switzerland; Virbac, Australia


  • Tickamit (veterinary use)
    Quifipor - Química Fina Portuguesa, Lda., Portugal


  • Topline (veterinary use)
    Hoechst Roussel Vet, Portugal; Hoechst Vet, Ireland; Intervet, United Kingdom


  • Triatix (Amitraz and Deltamethrin, + Piperonyl Butoxide (veterinary use))
    Afrivet, South Africa


  • Triatix (veterinary use)
    Afrivet, South Africa

International Drug Name Search

Glossary

BANBritish Approved Name
IUPACInternational Union of Pure and Applied Chemistry
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
Prop.INNProposed International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Inteban SP




Inteban SP may be available in the countries listed below.


Ingredient matches for Inteban SP



Indometacin

Indometacin is reported as an ingredient of Inteban SP in the following countries:


  • Japan

International Drug Name Search

Rubramin PC




Generic Name: cyanocobalamin

Dosage Form: injection, USP

Rubramin PC Description


Rubramin PC (Cyanocobalamin Injection) contains cyanocobalamin (vitamin B12) in a clear, red, sterile, nonpyrogenic, aqueous solution in a potency of 1000 mcg/mL (cobalt: 40 mcg/mL) for intramuscular use. Each mL of solution also contains 10 mg benzyl alcohol as a preservative and sodium chloride for isotonicity; pH has been adjusted between 4.5 and 7.0 with sodium hydroxide or hydrochloric acid.


Cyanocobalamin is very hygroscopic in the anhydrous form, and sparingly soluble in water (1:80). The vitamin B12 coenzymes are very unstable in light.


Cyanocobalamin may be chemically designated as 5,6-dimethyl-benzimidazolyl cyanocobamide. The structural formula is represented below:




Rubramin PC - Clinical Pharmacology


Vitamin B12 is essential to growth, cell reproduction, hematopoiesis, and nucleoprotein and myelin synthesis.


Cyanocobalamin is quantitatively and rapidly absorbed from intramuscular sites of injection; the plasma level of the compound reaches its peak within one hour after intramuscular injection. Absorbed vitamin B12 is transported via specific B12 binding proteins, transcobalamin I and II to the various tissues. The liver is the main organ for vitamin B12 storage.


Within 48 hours after injection of 1000 mcg of vitamin B12, 50 to 98 percent of the injected dose may appear in the urine. The major portion is excreted within the first eight hours.


Gastrointestinal absorption of vitamin B12 depends on the presence of sufficient intrinsic factor and calcium ions. Intrinsic factor deficiency causes pernicious anemia, which may be associated with subacute combined degeneration of the spinal cord. Prompt parenteral administration of vitamin B12 prevents progression of neurologic damage.


The average diet supplies about 5 to 15 mcg/day of vitamin B12 in a protein-bound form that is available for absorption after normal digestion. Vitamin B12 is not present in foods of plant origin, but is abundant in foods of animal origin. In people with normal absorption, deficiencies have been reported only in strict vegetarians who consume no products of animal origin (including milk products or eggs).


Vitamin B12 is bound to intrinsic factor during transit through the stomach; separation occurs in the terminal ileum in the presence of calcium, and vitamin B12 enters the mucosal cell for absorption. It is then transported by the transcobalamin binding proteins. A small amount (approximately 1 percent of the total amount ingested) is absorbed by simple diffusion, but this mechanism is adequate only with very large doses. Oral absorption is considered too unreliable in patients with pernicious anemia or other conditions resulting in malabsorption of vitamin B12.


Cyanocobalamin is the most widely used form of vitamin B12, and has hematopoietic activity apparently identical to that of the anti-anemia factor in purified liver extract. Hydroxycobalamin is equally as effective as cyanocobalamin, and they share the cobalamin molecular structure.



Indications and Usage for Rubramin PC


Rubramin PC is indicated for use as the flushing dose in the Schilling (vitamin B12 absorption) Test for pernicious anemia.



Contraindications


This preparation is contraindicated in patients who are sensitive to cobalt and/or vitamin B12.



Warnings


Patients who have early Leber’s disease (hereditary optic nerve atrophy) have been found to suffer severe and swift optic atrophy when treated with vitamin B12.


Fatal hypokalemia may occur when severe megaloblastic anemia is treated intensively with vitamin B12, as a result of increased erythrocyte potassium requirements (see PRECAUTIONS, Laboratory Tests).


Anaphylactic shock and death have been reported after parenteral vitamin B12 administration. An intradermal test dose is recommended before cyanocobalamin is administered to patients suspected of being sensitive to this drug.


This product contains benzyl alcohol. Benzyl alcohol has been reported to be associated with a fatal "Gasping Syndrome" in premature infants.



Precautions



General


Doses of vitamin B12 exceeding 10 mcg daily may produce a hematologic response in patients who have a folate deficiency. Indiscriminate administration of vitamin B12 may mask the true diagnosis of pernicious anemia.


Vitamin B12 deficiency that is allowed to progress for longer than three months may produce permanent degenerative lesions of the spinal cord. Doses of folic acid greater than 0.1 mg per day may result in hematologic remission in patients with vitamin B12 deficiency. Neurologic manifestations will not be prevented with folic acid, and if not treated with vitamin B12, irreversible damage will result.



Laboratory Tests


Patients with pernicious anemia have about three times the incidence of carcinoma of the stomach as the general population, so appropriate tests for this condition should be carried out when indicated.



Drug Interactions


Neomycin, colchicine, para-aminosalicylic acid, or excessive alcohol intake longer than two weeks may cause malabsorption of vitamin B12. Chloramphenicol and other drugs having bone marrow suppressant properties may cause a lack of therapeutic response to vitamin B12; this effect may be due to interference with erythrocyte maturation.



Drug/Laboratory Test Interactions


Most antibiotics, methotrexate, and pyrimethamine invalidate folic acid and vitamin B12 diagnostic microbiological blood assays.



Carcinogenesis, Mutagenesis, Impairment of Fertility


Long-term studies in animals to evaluate carcinogenic potential have not been done. There is no evidence from long-term use in patients with pernicious anemia that cyanocobalamin is carcinogenic. Pernicious anemia is associated with an increased incidence of carcinoma of the stomach, but this is believed to be related to the underlying pathology and not to treatment with cyanocobalamin.



Pregnancy


Pregnancy Category C. Adequate and well-controlled studies have not been done in pregnant women. However, vitamin B12 is an essential vitamin and requirements are increased during pregnancy. Amounts of vitamin B12 that are recommended by the Food and Nutrition Board, National Academy of Science-National Research Council for pregnant women (4 mcg daily) should be consumed during pregnancy.



Nursing Mothers


Vitamin B12 is known to be excreted in human milk. Amounts of vitamin B12 that are recommended by the Food and Nutrition Board, National Academy of Science-National Research Council for lactating women (4 mcg daily) should be consumed during lactation.


Vitamin B12 appears in the milk of nursing mothers in concentrations that approximate the mother’s vitamin B12 blood level.



Pediatric Use


Safety and effectiveness in pediatric patients has not been established.



Adverse Reactions


No serious toxic reactions have been reported following the intramuscular administration of cyanocobalamin. The following allergic-type reactions have been reported rarely; the relationship of these reactions to cyanocobalamin or other components in the preparation is unknown.


Generalized—anaphylactic shock and death have been reported with administration of parenteral vitamin B12 (see WARNINGS)


Cardiovascular—pulmonary edema and congestive heart failure early in treatment, peripheral vascular thrombosis


Hematologic—polycythemia vera


Gastrointestinal—mild transient diarrhea


Dermatologic—itching, transitory exanthema, urticaria


Miscellaneous—feeling of swelling of entire body



Overdosage


No overdosage has been reported with this drug.



Rubramin PC Dosage and Administration


Rubramin PC (Cyanocobalamin Injection) should be visually inspected for particulate matter and color prior to administration; the solution is clear red.


Do not administer intravenously.



Schilling Test*


The flushing dose is 1000 mcg injected intramuscularly. For procedure see the insert packaged with Rubratope®-57 (Cyanocobalamin Co 57) capsules or diagnostic kit (see the DOSAGE AND ADMINISTRATION section).



How is Rubramin PC Supplied


Rubramin PC (Cyanocobalamin Injection USP)


Unimatic® Single Dose Syringes


The syringes are supplied with sterile disposable 22-gauge, 1-1/4-inch needles.


     1000 mcg (1 mL):     NDC 0270-0519-16



Storage


Protect from light (keep syringes in carton). Store at controlled room temperature; avoid freezing.



Directions for Use of

UNIMATIC® single dose syringe


1)

Screw the threaded tip of the plunger rod clockwise into the cartridge plunger and push forward a few millimeters to break any friction between the cartridge plunger and syringe barrel.


2)

Holding syringe erect, aseptically remove the rubber cap from the tip of the syringe and attach the sterile, disposable needle using a push-twist action.


3)

Remove the needle guard, hold the syringe erect, and push plunger forward until a drop appears at tip of needle and all of the air is evacuated. Following the usual aspiration procedure complete the injection.


4)

Destroy the needle and syringe immediately after use.


Manufactured for

Bracco Diagnostics Inc.

Princeton, N.J. 08543

by E.R. Squibb & Sons Inc.

New Brunswick, N.J. 08903


J3-662G

Printed in USA

May 1995








Rubramin PC 
cyanocobalamin  injection, solution










Product Information
Product TypeHUMAN PRESCRIPTION DRUGNDC Product Code (Source)0270-0519
Route of AdministrationINTRAMUSCULARDEA Schedule    




















INGREDIENTS
Name (Active Moiety)TypeStrength
cyanocobalamin (cyanocobalamin)Active1000 MICROGRAM  In 1 MILLILITER
benzyl alcoholInactive10 MILLIGRAM  In 1 MILLILITER
sodium chlorideInactive 
sodium hydroxideInactive 
hydrochloric acidInactive 


















Product Characteristics
Color    Score    
ShapeSize
FlavorImprint Code
Contains      










Packaging
#NDCPackage DescriptionMultilevel Packaging
10270-0519-161 mL (MILLILITER) In 1 SYRINGENone

Revised: 10/2006Bristol-Myers Squibb Company

More Rubramin PC resources


  • Rubramin PC Side Effects (in more detail)
  • Rubramin PC Use in Pregnancy & Breastfeeding
  • Rubramin PC Drug Interactions
  • Rubramin PC Support Group
  • 5 Reviews for Rubramin PC - Add your own review/rating


Compare Rubramin PC with other medications


  • B12 Nutritional Deficiency
  • Pernicious Anemia
  • Schilling Test
  • Vitamin B12 Deficiency

Sinopryl




Sinopryl may be available in the countries listed below.


Ingredient matches for Sinopryl



Lisinopril

Lisinopril is reported as an ingredient of Sinopryl in the following countries:


  • Romania

  • Turkey

International Drug Name Search